Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Thrombosis”

479 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 479 results

Not applicableUnknownNCT00400504
What this trial is testing

Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)

Who this might be right for
Cancer
Rigshospitalet, Denmark 500
Not applicableLooking for participantsNCT07270263
What this trial is testing

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more
Medical University of Gdansk 100
Early research (Phase 1)UnknownNCT04104074
What this trial is testing

Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital 20
Testing effectiveness (Phase 2)UnknownNCT01834963
What this trial is testing

P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular Carcinoma
Kansai Hepatobiliary Oncology Group 66
Post-approval studies (Phase 4)Study completedNCT00942968
What this trial is testing

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Who this might be right for
Cancer
Pfizer 338
Testing effectiveness (Phase 2)Looking for participantsNCT06664996
What this trial is testing

Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 33
Not applicableStudy completedNCT00004875
What this trial is testing

Heparin or Enoxaparin in Patients With Cancer

Who this might be right for
LymphomaThromboembolismUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 6
Not applicableStudy completedNCT02739867
What this trial is testing

Tumor-educated Platelets in Venous Thromboembolism

Who this might be right for
NeoplasmsVenous Thromboembolism
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 476
Testing effectiveness (Phase 2)Looking for participantsNCT07483359
What this trial is testing

Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma (HCC)Portal Vein Tumor Thrombus
First Hospital of China Medical University 38
Not applicableStudy completedNCT04996693
What this trial is testing

On Dose Efficiency of Modern CT-scanners in Chest Scans

Who this might be right for
PneumoniaLung CancerPulmonary Embolism+2 more
University Hospital Augsburg 958
Not applicableUnknownNCT04502498
What this trial is testing

Preoperative Subclinical DVT Screening in Locally Advanced Bladder Cancer Patients Candidate for Radical Cystectomy.

Who this might be right for
Bladder Cancer Patients Candidate for Radical Cystectomy
Kasr El Aini Hospital 60
Large-scale testing (Phase 3)Study completedNCT00199602
What this trial is testing

Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients

Who this might be right for
Cancer
University Hospital, Limoges 420
Post-approval studies (Phase 4)WithdrawnNCT03167281
What this trial is testing

Early Intrapleural TPA Instillation Versus Late

Who this might be right for
Tissue Plasminogen Activator
Prisma Health-Midlands
Large-scale testing (Phase 3)Ended earlyNCT03090880
What this trial is testing

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)

Who this might be right for
Venous ThromboembolismLung Neoplasm
Assistance Publique - Hôpitaux de Paris 59
Large-scale testing (Phase 3)Ended earlyNCT00423683
What this trial is testing

Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism

Who this might be right for
CancerThromboembolism
Northwell Health 64
Not applicableUnknownNCT00192829
What this trial is testing

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Who this might be right for
Non-Small Cell Lung CarcinomaVenous Thromboembolism
Rambam Health Care Campus 100
Not applicableStudy completedNCT05532475
What this trial is testing

Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Kasr El Aini Hospital 40
Not applicableStudy completedNCT01444612
What this trial is testing

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

Who this might be right for
Thrombosis, Venous
GlaxoSmithKline 4,068
Large-scale testing (Phase 3)Not Yet RecruitingNCT06149533
What this trial is testing

Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients

Who this might be right for
Thrombosis, VenousCancerCatheter Complications
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 366
Not applicableUnknownNCT04814251
What this trial is testing

Portal Vein Thrombosis Associated With Unresectable Pancreatic Cancers : a Prospective Multicentric Cohort Study

Who this might be right for
Pancreatic Adenocarcinoma
Poitiers University Hospital 200
Next Page